LMU University Hospital Munich at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
LMU University Hospital Munich takes part in 7 sessions at ESMO 2026 in Madrid. Its program centres on molecular diagnostics and tumour-agnostic oncology, including interpreting tumour sequencing and low-risk germline variants. Other sessions cover surgery and first-line therapy for BRCA-mutated high-grade serous ovarian cancer and regulatory barriers to clinical trials.
| Organization | ESMO 2026 Attendance |
|---|---|
LMU University Hospital Munich Munich, Germany | |
Teaching hospital of Ludwig-Maximilians-Universität München, in Munich, Germany. | Talk Sat Oct 24 09:30–09:50 Talk Sun Oct 25 09:00 Talk Sun Oct 25 10:30–10:45 Chair Mon Oct 26 10:15–11:30 Optimal management of high-grade serous ovarian cancer with BRCA mutation Gynaecological cancers Talk Mon Oct 26 10:20–10:40 Surgery and first-line systemic therapy: How to choose among the different options? Gynaecological cancers Chair Mon Oct 26 12:00–12:50 What oncologists should know about interpreting tumour sequencing Biomarkers & precision oncology Talk Mon Oct 26 12:30–12:45 Interpreting low-risk germline variants Biomarkers & precision oncology Chair Mon Oct 26 14:45–16:15 Tumour-agnostic oncology: From concept to clinical practice Biomarkers & precision oncology Talk Tue Oct 27 12:00–12:20 Talk Tue Oct 27 12:20–12:40 |
Instantly find 20 buyers from LMU University Hospital Munich
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction